Stay updated on ADP-A2M4CD8 with Checkpoint Inhibitors in MAGE-A4+ Tumors Clinical Trial
Sign up to get notified when there's something new on the ADP-A2M4CD8 with Checkpoint Inhibitors in MAGE-A4+ Tumors Clinical Trial page.

Latest updates to the ADP-A2M4CD8 with Checkpoint Inhibitors in MAGE-A4+ Tumors Clinical Trial page
- Check2 days agoChange DetectedUpdated the study's Locations section with new site entries (Florida, Massachusetts, Missouri, New York, North Carolina, Oklahoma, Tennessee, Texas, Wisconsin, Ontario, Avenida de Cordoba S/n, Pamplona, and Valencia). The page revision was updated to v3.3.3 and related location subsections were removed.SummaryDifference1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page's revision label was updated from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check30 days agoChange DetectedThe page revision was updated from v3.2.0 to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check37 days agoChange DetectedRemoval of the government funding status notice from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check52 days agoChange DetectedOnly non-substantive updates appear on the page (for example, last updated timestamp). The core study details, eligibility criteria, and treatment arms remain unchanged.SummaryDifference0.4%

- Check80 days agoChange DetectedAdded a government operating-status notice and updated version to v3.2.0; removed the specific resource label “Carcinoma of esophagus” and v3.1.0 reference.SummaryDifference4%

Stay in the know with updates to ADP-A2M4CD8 with Checkpoint Inhibitors in MAGE-A4+ Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADP-A2M4CD8 with Checkpoint Inhibitors in MAGE-A4+ Tumors Clinical Trial page.